Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000049

EVP, Business Operations sold 37,279 shares at an average $99.30 ($3,701,647)

  • EVP, Business Operations acquired 37,279 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Havey Adam · EVP, Business Operations

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Exercise or conversion : show line 1 in the form +17,134 $30.63 $524,814 55,324 D
2021-03-01 Sale : show line 2 in the form −17,134 $99.62 $1,706,889 38,190 D
2021-03-01 Exercise or conversion : show line 3 in the form +20,145 $49.64 $999,998 58,335 D
2021-03-01 Sale : show line 4 in the form −20,145 $99.02 $1,994,758 38,190 D
Open-market sales · 37,279 sh · avg $99.30 · $3,701,647

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −17,134 $99.62 $1,706,889 0 D
2021-03-01 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −20,145 $99.02 $1,994,758 0 D
Loading xslF345X03/wf-form4_161481282979100.xml…